Navigation Links
Study Unblinded: ZYTIGA® (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer
Date:3/8/2012

ution in patients with a history of cardiovascular disease or with medical conditions that might be compromised by increases in hypertension, hypokalemia, and fluid retention. ZYTIGA® may cause hypertension, hypokalemia, and fluid retention as a consequence of increased mineralocorticoid levels resulting from CYP17 inhibition. Safety has not been established in patients with LVEF <50% or New York Heart Association (NYHA) Class III or IV heart failure because these patients were excluded from the randomized clinical trial. Control hypertension and correct hypokalemia before and during treatment. Monitor blood pressure, serum potassium, and symptoms of fluid retention at least monthly.

Adrenocortical Insufficiency (AI) - AI has been reported in clinical trials in patients receiving ZYTIGA® in combination with prednisone, after an interruption of daily steroids and/or with concurrent infection or stress. Use caution and monitor for symptoms and signs of AI if prednisone is stopped or withdrawn, if prednisone dose is reduced, or if the patient experiences unusual stress. Symptoms and signs of AI may be masked by adverse reactions associated with mineralocorticoid excess seen in patients treated with ZYTIGA®. Perform appropriate tests, if indicated, to confirm AI. Increased dosages of corticosteroids may be used before, during, and after stressful situations.

Hepatotoxicity - Increases in liver enzymes have led to drug interruption, dose modification, and/or discontinuation. Monitor liver function and modify, withhold, or discontinue ZYTIGA® dosing as recommended (see Prescribing Information for more information). Measure serum transaminases [alanine aminotransferase (ALT) and aspartate aminotransferase (AST)] and bilirubin levels prior to starting treatment with ZYTIGA®, every two weeks for the first three months of treatment, and monthly thereafter.  Promptly measure serum total bilirubin, AST, and ALT if cli
'/>"/>

SOURCE Janssen Research & Development, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... -- The amount Americans spend on healthcare out of ... of 8% will reach $608 billion by 2019.  Americans ... expenditures, co-pays as part of office visits and hospital ... made its finding in its most recent report ... . Information on the report ...
(Date:5/28/2015)... May 28, 2015  The U.S. Department of Justice ... Inc. and Rehab Medical Inc. to resolve a lawsuit ... filing of a whistleblower lawsuit by two former employees ... under the direction of one of Orbit,s top executives, ... Orbit could obtain payment from Medicare for electric wheelchairs. ...
(Date:5/28/2015)... , May 28, 2015 ... titled, "Global mHealth Market (Device, Service, Application, Stakeholders and ... Forecast, 2014-2020", stated that the global mHealth market ... is expected to grow at a CAGR of ... largest share in the global mHealth device market ...
Breaking Medicine Technology:Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 2Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 3Electric Wheelchair Sellers Agree To $7.5 Million Settlement Of Whistleblower Case Alleging That Company Forged Medical Records As Part Of Scheme To Defraud Medicare 2Electric Wheelchair Sellers Agree To $7.5 Million Settlement Of Whistleblower Case Alleging That Company Forged Medical Records As Part Of Scheme To Defraud Medicare 3Electric Wheelchair Sellers Agree To $7.5 Million Settlement Of Whistleblower Case Alleging That Company Forged Medical Records As Part Of Scheme To Defraud Medicare 4mHealth Market to Grow at an Impressive CAGR of 33.5% During 2015 - 2020 - Allied Market Research 2mHealth Market to Grow at an Impressive CAGR of 33.5% During 2015 - 2020 - Allied Market Research 3mHealth Market to Grow at an Impressive CAGR of 33.5% During 2015 - 2020 - Allied Market Research 4
... 2011 Centers for Disease Control and Prevention ... Epicenter as part of its program to conduct ... Infections, or HAIs, with the goal of saving ... system was selected by Duke University after successful ...
... Cephalon, Inc. (Nasdaq: CEPH ) announced that ... the validity of Cephalon,s U.S. Patent Number 6,264,981 patent and ... FENTORA® (fentanyl buccal tablet) infringes that patent.  The Court ... injunction preventing Watson from marketing its product. ...
Cached Medicine Technology:$2 Million Awarded to Duke University Prevention Epicenter to Study Reduction of Healthcare-Associated Infections Using Tru-D, Total Room Ultraviolet Disinfection 2Cephalon Wins FENTORA Patent Suit Against Watson 2Cephalon Wins FENTORA Patent Suit Against Watson 3
(Date:5/28/2015)... 2015 The partners of Urgent Care ... present Dr. Alicia Almendral as their chief provider for ... of the newly opened facility’s plan to offer all ... treatments. , Dr. Almendral is a board certified physician ... and cosmetic enhancement techniques. Her areas of expertise include ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Success ... 351(k) Application Process, **FDAnews Webinar**, June 23, 2015 ... [http://www.fdanews.com/BiosimilarsApproval , On June 23, 2015, FDAnews ... two leading intellectual property attorneys from the international ... Strategies for Biosimilars Approval: A Roadmap to the ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 The Boys & ... $2,500 from Horizon Blue Cross Blue Shield of New Jersey ... Natalie Gulbis, the club can receive much more support as ... Acer. , A former Boys & Girls Club member and ... Sacramento, California, Ms. Gulbis has accepted the Horizon Blue Cross ...
(Date:5/28/2015)... AMVETS leaders this week congratulated AMVETS 2015 ... of Newark, Del. AMVETS National Commander Larry Via personally ... $10,000 sweepstakes grand prize. , AMVETS selected the 10 ... the country for prizes ranging from $500 to the ... 21 at the AMVETS National Headquarters in Lanham, MD. ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 As the summer ... to keep cool. It’s important to make safety a top ... sharing some swimming tips. , According to the Centers for ... the United States, not including boating incidents. Additionally, the National ... for children ages 1 to 4. , Amica is ...
Breaking Medicine News(10 mins):Health News:Bella Diosa Med Spa Welcomes Botox Specialist to Yonkers Community 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 3Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 2Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 3Health News:AMVETS Announces Summer Sweepstakes Winners 2Health News:Splash! Amica Shares 6 Swimming Safety Tips 2
... The World Health Assembly has given a powerful endorsement ... The strategy brings together crucial elements to reduce childhood ... reduce the 1.4 million adolescent deaths each year. ,Last ... was double the total number of adult deaths from ...
... Recent findings from the University of Hong Kong and,the Shenzhen ... virus from,animals. The findings are observed form a study conducted ... five out of the ten were found to have SARS ... them reported to be sick, thus suggesting that the workers ...
... its border with hard-hit China. ,The first confirmed case of ... Amur river, which forms the frontier with China, came as ... country could contain the disease.,Hu told students in Moscow, at ... strict measures to stop the spread of the deadly virus ...
... people over age 85 have Alzheimer’s disease. Now, researchers ... some postmenopausal women to develop dementia, which is a ... from Wake Forest University studied more than 4,500 postmenopausal ... Initiative. The WHI came to an early end last ...
... 2,000 people possibly exposed to the illness have been ... said Dr. Colin D'Cunha, Ontario's chief medical officer of ... since the outbreak could not control dozens of possible ... the WHO put Canada`s largest city back on its ...
... of a new form of deadly pneumonia is on the ... virus was first detected in South China Asia and is ... World Health Organization the follwing cases of SARS that have ... May 23:// , ,Total number of probable cases: 8,046 , ...
Cached Medicine News:Health News:Hope for 11 million children facing death from illnesses 2Health News:WHO Says Toronto Going Back on SARS-Affected List 2
... Made with elastic fabric, these head ... you need to begin testing. Each Electro-Cap ... to the International 10-20 System. When you ... you are using with your head cap ...
... implant was conceived by Arthur C. Perry, ... comprehensive review of the literature on orbital ... back to 1885 (Mules 1885). This review, ... performance of contemporary implants, allowed Perry to ...
... Spheres for Enucleation and Evisceration. ... combine the structure of standard MEDPOR ... mixture. The Bioglass component, mixed throughout ... fibrovascular ingrowth into the MEDPOR PLUS ...
... ICL and the TORIC ICL are posterior ... STAARs proprietary collagen copolymer, the lens rests ... This unique material contains a small amount ... superior optical capability. The lens is gently ...
Medicine Products: